Lilly (LLY) announces analysis performed by Washington University School of Medicine in DIAN-TU Study showed solanezumab did not meet primary endpoint

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. SPY
3. ABBV
4. META
5. MU
6. ACN
7. NVDA
8. BLZE
9. IBM
10. PRIM

Go back to Lilly (LLY) announces analysis performed by Washington University School of Medicine in DIAN-TU Study showed solanezumab did not meet primary endpoint
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1108.26 +6.18 (0.56%)
Previous Close $1102.08    52 Week High $88.16 
Open $1117.00    52 Week Low $67.88 
Day High $1122.02    P/E 256.54 
Day Low $1079.22    EPS $4.32 
Volume 2,467,954